Experts: Regulations On Abortion Pill ‘No Longer Makes Clinical Sense’
Specialists in obstetrics and gynecology, public health and regulatory law weigh in on restrictions surrounding Mifeprex.
Los Angeles Times:
Are Restrictions On The 'Abortion Pill' Politics Or Science?
The Food and Drug Administration’s restrictions on the dispensing of mifepristone — one half of the two-drug cocktail used to end a pregnancy in its first 10 weeks — “no longer makes clinical sense” and should be “expeditiously withdrawn,” experts argue in the New England Journal of Medicine. As a key component of a “medical” abortion, the drug marketed as Mifeprex has been controversial from the start. After it was approved for marketing in the United States in 2000, anti-abortion activists tried to limit its use by pressing the FDA to narrowly circumscribe the ways it can be prescribed, dispensed and used. Then they pushed for states to enact laws requiring strict adherence to the FDA rules. A handful of states complied. (Healy, 2/24)